ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 45 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,750 | -24.9% | 855 | 0.0% | 0.00% | – |
Q2 2023 | $6,322 | -21.4% | 855 | 0.0% | 0.00% | – |
Q1 2023 | $8,044 | -10.9% | 855 | 0.0% | 0.00% | – |
Q4 2022 | $9,026 | +50.4% | 855 | 0.0% | 0.00% | – |
Q3 2022 | $6,000 | +50.0% | 855 | 0.0% | 0.00% | – |
Q2 2022 | $4,000 | 0.0% | 855 | 0.0% | 0.00% | – |
Q1 2022 | $4,000 | -20.0% | 855 | 0.0% | 0.00% | – |
Q4 2021 | $5,000 | – | 855 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Corton Capital Inc. | 13,966 | $103,000 | 0.13% |
Delphia (USA) Inc. | 14,226 | $105,000 | 0.12% |
Sentinus, LLC | 22,500 | $166,000 | 0.10% |
Intrepid Financial Planning Group LLC | 20,000 | $148,000 | 0.08% |
PERRITT CAPITAL MANAGEMENT INC | 12,000 | $89,000 | 0.06% |
J. Goldman & Co LP | 148,738 | $1,098,000 | 0.05% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 88,966 | $657,000 | 0.02% |
EMFO, LLC | 1,666 | $12,000 | 0.01% |
Virtu Financial LLC | 12,590 | $93,000 | 0.01% |
Jump Financial, LLC | 23,400 | $173,000 | 0.01% |